A carregar...
Topotecan: An evolving option in the treatment of relapsed small cell lung cancer
The topoisomerase I inhibitor topotecan is the only single-agent therapy approved for the treatment of recurrent small cell lung cancer (SCLC). Many patients with recurrent SCLC may be predisposed to treatment-related adverse events because of the presence of comorbidities such as advanced age, rena...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2387299/ https://ncbi.nlm.nih.gov/pubmed/18516270 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|